NCT04557293 Effort-based Decision-making and CPAP Adherence
| NCT ID | NCT04557293 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istituti Clinici Scientifici Maugeri SpA |
| Condition | Obstructive Sleep Apnea |
| Study Type | INTERVENTIONAL |
| Enrollment | 64 participants |
| Start Date | 2021-03-10 |
| Primary Completion | 2026-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 64 participants in total. It began in 2021-03-10 with a primary completion date of 2026-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Obstructive sleep apnoea is the most common sleep disorder in general population, and is often associated with cognitive deficit, mood disorders, hypertension, diabetes mellitus, excessive daytime somnolence, nicturia and an increased cardiovascular and metabolic risk. The gold standard of treatment is Continuous Positive Airway Pressure (CPAP), but the adherence is often poor. The aim of our study is to investigate the effort based-decision making in patients with OSA, pre and post CPAP treatment, as a possible cause of poor adherence.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 * AHI±15 Exclusion Criteria: * BMI ≥ 35 Kg/m2 * MMSE \<24 * Complex sleep apnoea * Sleep disorder * Psychiatric disorder
Contact & Investigator
Nicola Canessa, PhD
PRINCIPAL INVESTIGATOR
IRCCS Istituti Clinici Scientifici Maugeri - Scuola superiore IUSS Pavia
Frequently Asked Questions
Who can join the NCT04557293 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Obstructive Sleep Apnea. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04557293 currently recruiting?
Yes, NCT04557293 is actively recruiting participants. Contact the research team at nicola.canessa@icsmaugeri.it for enrollment information.
Where is the NCT04557293 trial being conducted?
This trial is being conducted at Pavia, Italy.
Who is sponsoring the NCT04557293 clinical trial?
NCT04557293 is sponsored by Istituti Clinici Scientifici Maugeri SpA. The principal investigator is Nicola Canessa, PhD at IRCCS Istituti Clinici Scientifici Maugeri - Scuola superiore IUSS Pavia. The trial plans to enroll 64 participants.